North America Cell Lysis And Disruption Market Size & Outlook
North America cell lysis and disruption market, 2018-2028 (US$M)
Related Markets
North America cell lysis and disruption market highlights
- The North America cell lysis and disruption market generated a revenue of USD 1,693.8 million in 2020.
- The market is expected to grow at a CAGR of 8.6% from 2021 to 2028.
- In terms of segment, reagent-based was the largest revenue generating technique in 2020.
- Physical Disruption is the most lucrative technique segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2021 to 2028.
North America data book summary
| Market revenue in 2020 | USD 1,693.8 million |
| Market revenue in 2028 | USD 3,278.7 million |
| Growth rate | 8.6% (CAGR from 2020 to 2028) |
| Largest segment | Reagent-based |
| Fastest growing segment | Physical Disruption |
| Historical data covered | 2018 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Reagent-based, Physical Disruption |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Bio-Rad Laboratories Inc, Roche Holding AG ADR, Qiagen NV, Danaher Corp, Miltenyi Biotec, IDEX Corp, BD, Claremont BioSolutions, Parr Instrument Company, Covaris, Cell Signaling Technology, Qsonica |
Other key industry trends
- In terms of revenue, North America region accounted for 41.4% of the global cell lysis and disruption market in 2020.
- Globally, North America is projected to lead the regional market in terms of revenue in 2028.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,195.9 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell Lysis And Disruption Market Scope
Cell Lysis And Disruption Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America cell lysis and disruption market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell lysis and disruption market will help companies and investors design strategic landscapes.
Reagent-based was the largest segment with a revenue share of 69.62% in 2020. Horizon Databook has segmented the North America cell lysis and disruption market based on reagent-based, physical disruption covering the revenue growth of each sub-segment from 2018 to 2028.
Presence of innovators and key players has resulted in an increased market penetration of products in the region. North America leads the cell lysis & disruption market along with other emerging markets that require strong biotechnology and R&D
presence, such as genomics, proteomics, oncology, diagnostic screening, and drug discovery. In addition, highly ranked genetic research programs are conducted by universities in the U.S. and Canada. These have driven the demand for cell lysis & disruption methods in North America.
Moreover, rise in prevalence of chronic disorders and adoption of personalized medicine approach in treatment of life threatening disorders would drive the market growth. Strong regulatory framework for drug approval.
Reasons to subscribe to North America cell lysis and disruption market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America cell lysis and disruption market databook
-
Our clientele includes a mix of cell lysis and disruption market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America cell lysis and disruption market , including forecasts for subscribers. This continent databook contains high-level insights into North America cell lysis and disruption market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
North America cell lysis and disruption market size, by country, 2018-2028 (US$M)
North America Cell Lysis And Disruption Market Outlook Share, 2020 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
